If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDE.L Regulatory News (IDE)

  • There is currently no data for IDE

Board Change

10 Jan 2018 07:00

RNS Number : 4215B
IDE Group Holdings PLC
10 January 2018
 

IDE Group Holdings Plc

("IDE Group" or the "Group")

Board Change

 

IDE Group Holdings plc (AIM: IDE), the mid-market network, cloud and IT managed services provider, announces today that Non-Executive Chairman Jonathan Watts has advised that he wishes to step down from the Board of the Company due to health reasons. Jonathan has agreed to continue in his current role until the end of January 2018 to enable a smooth transition to current Non-Executive Director Bill Dobbie who will step in as interim Chairman.

Bill Dobbie commented: "On behalf of the Board, I would like to thank Jonathan for his constant dedication to the Group. Jonathan has been a vital asset in building IDE Group to what it is today. We wish him all the very best for the future."

 

For further information please contact:

IDE Group Holdings Plc

Andy Ross, CEO

Julian Phipps, CFO

 

Tel: +44 (0)344 874 1000

N+1 Singer

Nominated Adviser and Broker

James Maxwell

Jen Boorer

 

Tel: +44 (0)207 496 3000

Alma PR Limited

Rebecca Sanders-Hewett

Robyn Fisher

Tel: +44 (0) 208 004 4218

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABLMMTMBBMTFP
Date   Source Headline
20th Apr 20217:00 amRNSDirectorate Change
15th Feb 20217:00 amRNSResignation of Director
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 202111:06 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:00 pmRNSPrice Monitoring Extension
28th Jan 202111:05 amRNSSecond Price Monitoring Extn
28th Jan 202111:00 amRNSPrice Monitoring Extension
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
4th Jan 20217:00 amRNSContract Win
24th Dec 202011:06 amRNSSecond Price Monitoring Extn
24th Dec 202011:00 amRNSPrice Monitoring Extension
24th Dec 20209:05 amRNSSecond Price Monitoring Extn
24th Dec 20209:00 amRNSPrice Monitoring Extension
4th Dec 20202:06 pmRNSSecond Price Monitoring Extn
4th Dec 20202:00 pmRNSPrice Monitoring Extension
3rd Dec 20204:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20204:35 pmRNSPrice Monitoring Extension
2nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:01 pmRNSPrice Monitoring Extension
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:00 amRNSPrice Monitoring Extension
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
20th Nov 20202:06 pmRNSSecond Price Monitoring Extn
20th Nov 20202:01 pmRNSPrice Monitoring Extension
16th Nov 202010:11 amRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSHalf-year Report
4th Sep 202011:24 amRNSResult of AGM
10th Aug 202012:05 pmRNSNotice of Annual General Meeting
14th Jul 20207:00 amRNSFinal Results
30th Jun 20207:00 amRNSDelay of Full Year Results and Trading Update
5th Jun 202012:17 pmRNSChange of Directorate Position
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
24th Feb 20202:16 pmRNSHolding(s) in Company
20th Feb 20203:24 pmRNSDirector/PDMR Shareholding
15th Jan 20202:32 pmRNSDirector/PDMR Shareholding
30th Dec 20197:00 amRNSIssue of Loan Notes and Contract Wins
13th Nov 20199:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.